AIM: To assess the validity of the Milan and University of California San Francisco (UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation (OLT) in patients with hepatocellular carcinoma (HCC) in a single-center study. METHODS: This study is a retrospective review of prospectively collected data. Between 1998 and 2009, 56 of 356 OLTs were performed in patients with HCC. Based on pathological examination of liver explants, patients were retrospectively categorized into 3 grou-ps: Milan + (n = 34), Milan -/UCSF + (n = 7) and UCSF - (n = 14). RESULTS: Median follow-up period was 39.5 (1-124) mo. The 5-year overall survival rates in the Milan +, Milan -/UCSF + and UCSF-groups were 87.7%, 53.6% and 33.3%, respectively (P < 0.000). Within these groups, tumor recurrence was determined in 5.8%, 14.3% and 40% of patients, respectively (P < 0.011). Additionally, the presence of microvascular invasion within the explanted liver had a negative effect on the 5-year disease free survival (74.7% vs. 46.7%, P < 0.044). CONCLUSION: The Milan criteria are reliable in the selection of suitable candidates for OLT for the treatment of HCC. For cases of OLT involving living donors, the UCSF criteria may be applied.
AIM: To assess the validity of the Milan and University of California San Francisco (UCSF) criteria and examine the long-term outcome of orthotopic liver transplantation (OLT) in patients with hepatocellular carcinoma (HCC) in a single-center study. METHODS: This study is a retrospective review of prospectively collected data. Between 1998 and 2009, 56 of 356 OLTs were performed in patients with HCC. Based on pathological examination of liver explants, patients were retrospectively categorized into 3 grou-ps: Milan + (n = 34), Milan -/UCSF + (n = 7) and UCSF - (n = 14). RESULTS: Median follow-up period was 39.5 (1-124) mo. The 5-year overall survival rates in the Milan +, Milan -/UCSF + and UCSF-groups were 87.7%, 53.6% and 33.3%, respectively (P < 0.000). Within these groups, tumor recurrence was determined in 5.8%, 14.3% and 40% of patients, respectively (P < 0.011). Additionally, the presence of microvascular invasion within the explanted liver had a negative effect on the 5-year disease free survival (74.7% vs. 46.7%, P < 0.044). CONCLUSION: The Milan criteria are reliable in the selection of suitable candidates for OLT for the treatment of HCC. For cases of OLT involving living donors, the UCSF criteria may be applied.
Entities:
Keywords:
Hepatobiliary pathology; Hepatobiliary radiology; Hepatobiliary surgery; Hepatocellular carcinoma; Liver malignancy; Liver transplantation; Living donor liver transplantation; Living related liver transplantation; Oncologic surgery; Survival; Transplant
Authors: J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés Journal: J Hepatol Date: 2001-09 Impact factor: 25.083
Authors: C Loinaz; M Abradelo; R Gómez; F Colina; P Rey; F Ochando; A R Cañete; I González-Pinto; C Jiménez; I García; E M González Journal: Transplant Proc Date: 1998-11 Impact factor: 1.066
Authors: A K Chui; A R Rao; G W McCaughan; R Waugh; D J Verran; D Koorey; D Painter; A G Sheil Journal: Clin Transplant Date: 1999-12 Impact factor: 2.863
Authors: V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari Journal: N Engl J Med Date: 1996-03-14 Impact factor: 176.079
Authors: Savio G Barreto; Simone I Strasser; Geoffrey W McCaughan; Michael A Fink; Robert Jones; John McCall; Stephen Munn; Graeme A Macdonald; Peter Hodgkinson; Gary P Jeffrey; Bryon Jaques; Michael Crawford; Mark E Brooke-Smith; John W Chen Journal: Cancers (Basel) Date: 2022-06-03 Impact factor: 6.575
Authors: Jorge Henrique Bento de Sousa; Igor Lepski Calil; Francisco Tustumi; Douglas da Cunha Khalil; Guilherme Eduardo Gonçalves Felga; Rafael Antonio de Arruda Pecora; Marcio Dias de Almeida Journal: Transl Gastroenterol Hepatol Date: 2021-01-05
Authors: Bjarte Fosby; Espen Melum; Kristian Bjøro; William Bennet; Allan Rasmussen; Ina Marie Andersen; Maria Castedal; Michael Olausson; Christina Wibeck; Mette Gotlieb; Henrik Gjertsen; Leena Toivonen; Stein Foss; Heikki Makisalo; Arno Nordin; Truls Sanengen; Annika Bergquist; Marie E Larsson; Gunnar Soderdahl; Greg Nowak; Kirsten Muri Boberg; Helena Isoniemi; Susanne Keiding; Aksel Foss; Pål-Dag Line; Styrbjörn Friman; Erik Schrumpf; Bo-Göran Ericzon; Krister Höckerstedt; Tom H Karlsen Journal: Scand J Gastroenterol Date: 2015-06 Impact factor: 2.423